PHARM Exam 1 AI Generated, but reviewed by me; (No specific Meds Mentioned)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/212

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 8:18 PM on 8/28/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

213 Terms

1
New cards

Clinical judgment

The use of critical thinking and decision-making skills to safely administer medications and monitor patient responses.

2
New cards

Medication reconciliation during Recognize Cues

Review new drug orders and compare them with medications the patient has been taking at home to avoid omission, duplication, or drug interactions.

3
New cards

First step in health teaching

Build trust and assess the patient's readiness to learn.

4
New cards

What should be assessed before medication teaching?

Educational level, health literacy, motor skills, and abilities.

5
New cards

What should patients learn about medications?

Purpose, indications, dosage schedule, correct administration, food and fluid restrictions, storage, therapeutic effects, side effects, adverse effects, drug interactions, and adherence strategies.

6
New cards

Teach-Back: Triage

Focus on one topic at a time.

7
New cards

Teach-Back: Tools

Use a model or visual aid to help the patient understand.

8
New cards

Teach-Back: Take responsibility

Say, "I want to make sure I did a good job teaching," rather than "I want to make sure you understood me."

9
New cards

Teach-Back: Tell me

Have the patient explain the information back to make sure they understand it.

10
New cards

Teach-Back: Try again

Reteach the information if needed.

11
New cards

Comprehensive Drug Abuse Prevention and Control Act

A 1970 federal law that created a scheduling system for controlled substances.

12
New cards

Schedule I

Not approved for medical use and has high potential for abuse.

13
New cards

Schedules II through V

Approved for medical use with decreasing potential for misuse leading to psychological and/or physical dependence.

14
New cards

Chemical name

The name that describes a drug's chemical structure.

15
New cards

Generic name

The non-proprietary name for a drug.

16
New cards

Trade or brand name

The name chosen by the drug company and usually trademarked; a drug may have many brand names.

17
New cards

Generic vs trade-name drugs

The active ingredient is the same; the difference is the fillers, and they must be bioequivalent.

18
New cards

Bioequivalence

The comparison showing that generic and trade-name drugs have equivalent therapeutic effects.

19
New cards

A rating related to bioequivalence

Indicates a drug is considered therapeutically equivalent.

20
New cards

Pharmacokinetics

The movement of a drug through the body and what the body does to the drug.

21
New cards

ADME

Absorption, Distribution, Metabolism, and Excretion.

22
New cards

Absorption

The movement of the drug into the bloodstream after administration.

23
New cards

What affects absorption?

Route of administration, age, weight, and health status.

24
New cards

Enteral administration

Administration by mouth; approximately 80% of medications are given this way.

25
New cards

Dissolution

The time it takes for a drug to disintegrate into small particles and combine with liquid to form a solution.

26
New cards

Distribution

The movement of a drug from the circulation to body tissues.

27
New cards

What affects distribution?

Vascular permeability, cell membrane permeability, blood-brain barrier, placenta, blood flow, pH, and cardiac output.

28
New cards

Metabolism

The process by which the body chemically changes drugs into a form that can be excreted.

29
New cards

Primary site of drug metabolism

Liver.

30
New cards

Secondary site of drug metabolism

Kidneys.

31
New cards

P450 or cytochrome P450 system

The enzyme system used by the liver for drug metabolism.

32
New cards

What happens when drug metabolism is decreased?

Excess drug accumulation can occur and lead to toxicity.

33
New cards

Excretion

The elimination of drugs from the body.

34
New cards

Main route of drug excretion

Kidneys.

35
New cards

Prerenal conditions

Conditions such as dehydration or hemorrhage that decrease blood flow and glomerular filtration.

36
New cards

Intrarenal conditions

Conditions such as glomerulonephritis or chronic kidney disease that affect filtration, secretion, and reabsorption.

37
New cards

Postrenal conditions

Conditions such as prostatic hypertrophy, stones, or neurogenic bladder that obstruct urine flow.

38
New cards

Enteric-coated medications

Medications that resist disintegration in the stomach and pass into the small intestine where the coating dissolves and absorption occurs.

39
New cards

Can enteric-coated tablets be crushed?

No.

40
New cards

Can sustained-release capsules be crushed?

No.

41
New cards

Pharmacodynamics

The study of the effects of drugs on the body.

42
New cards

Primary drug effect

The desirable, intended response.

43
New cards

Secondary drug effect

An effect that may be desirable or undesirable.

44
New cards

Onset

The time for a drug to reach the minimum effective concentration.

45
New cards

Peak

The time when a drug reaches its highest blood concentration.

46
New cards

Duration of action

The length of time the drug exerts its therapeutic effect.

47
New cards

Agonist

A drug that activates receptors and produces a desired response.

48
New cards

Partial agonist

A drug that produces only moderate activity when binding to receptors and can also prevent receptor activation by other drugs.

49
New cards

Antagonist

A drug that prevents receptor activation and blocks a response.

50
New cards

Bioavailability

The percentage of an administered drug available for activity.

51
New cards

IV bioavailability

100%.

52
New cards

Oral bioavailability

Always less than 100% and varies based on absorption and first-pass metabolism.

53
New cards

First-pass metabolism

An orally absorbed drug travels through the portal vein to the liver, where some of the drug is metabolized to an inactive form and excreted, reducing active drug available.

54
New cards

Routes that bypass first-pass metabolism

Intravenous, intramuscular, subcutaneous, nasal, sublingual, and buccal routes.

55
New cards

Protein binding

The distribution of drugs into plasma where many drugs bind to plasma proteins.

56
New cards

Highly protein-bound drug

A drug that is 90% bound to protein.

57
New cards

Weakly protein-bound drug

A drug that is less than 10% bound to protein.

58
New cards

Free drug

The unbound portion of the drug that remains active and can reach its site of action.

59
New cards

What happens when two highly protein-bound drugs are given together?

They compete for protein-binding sites, increasing the free drug released into circulation.

60
New cards

Why can protein-binding competition cause toxicity?

More free drug is available in the bloodstream and can interact with tissue receptors.

61
New cards

Half-life

The time it takes for the amount of drug in the body to be reduced by half.

62
New cards

What affects half-life?

Liver and kidney function.

63
New cards

What happens to half-life when metabolism or excretion is impaired?

The half-life is prolonged.

64
New cards

Why is half-life important?

It helps determine how often a patient should receive a medication.

65
New cards

Peak drug level

The highest plasma concentration of a drug at a specific time.

66
New cards

What does a peak level indicate?

It provides information about drug absorption.

67
New cards

Typical oral peak level

Usually 2-3 hours after oral administration.

68
New cards

Typical IV infusion peak level

Usually 30-60 minutes after IV infusion.

69
New cards

What does a low peak indicate?

The minimum effective concentration has not been met.

70
New cards

Trough drug level

The lowest plasma concentration of a drug, drawn just before the next dose regardless of route.

71
New cards

Drug toxicity

When the drug exceeds the therapeutic range.

72
New cards

What can cause drug toxicity?

Overdose or drug accumulation.

73
New cards

Risk factors for drug toxicity

Disease, genetics, and age.

74
New cards

Side effects

Secondary effects of a drug that are expected.

75
New cards

Adverse drug reactions

Unintentional, unexpected effects that occur with normal dosages and are always undesirable.

76
New cards

Drug interaction

An altered or modified interaction or effect of a drug resulting from interactions with one or more other drugs.

77
New cards

Risk factors for drug interactions

Chronic health conditions, multiple medications, multiple healthcare providers, and multiple pharmacies.

78
New cards

Population at highest risk for drug interactions

Older adults because of polypharmacy and sometimes having multiple healthcare providers.

79
New cards

Pharmacodynamic drug interaction

An interaction involving additive, synergistic, or antagonistic drug effects.

80
New cards

Additive drug effect

Increasing the response beyond what the drug could do by itself.

81
New cards

Example of additive drug effect

Beta blocker and diuretic.

82
New cards

Synergistic drug effect

One drug has a synergistic effect on another, increasing the effect.

83
New cards

Antagonistic drug effect

One drug stops the effect of another.

84
New cards

Phytomedicine

Plants or herbs with therapeutic or healing properties that may be preventative or therapeutic.

85
New cards

Botanicals

A plant or plant part valued for medicinal or therapeutic properties.

86
New cards

How are herbal supplements classified?

As dietary supplements.

87
New cards

Do herbal supplements require FDA approval before being sold?

No.

88
New cards

What must herbal supplement manufacturers follow?

Good manufacturing practices to ensure consistent processing and quality.

89
New cards

What claims can herbal supplement companies make?

General health, structure/function, or nutrient-deficiency claims if supported by data or research.

90
New cards

What claims can herbal supplement companies NOT make?

They cannot claim a supplement diagnoses, treats, cures, or prevents a specific disease.

91
New cards

FDA disclaimer for supplement claims

"This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease."

92
New cards

How does FDA oversight of supplements compare with prescription drugs?

Dietary supplements have minimal FDA oversight compared with prescription drugs.

93
New cards

When does the FDA monitor supplements?

After they are on the market.

94
New cards

What can the FDA do if a supplement is unsafe?

Issue warnings, take action against the manufacturer or distributor, or require removal from the market.

95
New cards

What must herbal supplement labels include?

Product name, net quantity, Supplement Facts, complete ingredient list, and manufacturer's or distributor's name and address.

96
New cards

Reliable sources for herbal supplement information

National Center for Complementary and Integrative Health and the Office of Dietary Supplements.

97
New cards

Why should nurses ask about herbal supplements?

They can interact with medications and cause adverse effects.

98
New cards

Patients requiring extra caution with herbal supplements

Pregnant patients, breastfeeding patients, patients preparing for surgery, patients younger than 18, and patients older than 65.

99
New cards

Herbal monograph

An organized source of information about a specific herb that may include botanical and pharmaceutical information.

100
New cards

Important rule about herbal supplements

Natural does not mean safe.